Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Phase 1-2 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2013 by ImmunoVaccine Technologies, Inc..
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by (Responsible Party):
ImmunoVaccine Technologies, Inc.
ClinicalTrials.gov Identifier:
NCT01416038
First received: August 9, 2011
Last updated: January 16, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)